ABH Healthcare Limited is a company in the healthcare business that people are talking about. This is because they have filed a document called a Draft Red Herring Prospectus. The company did this on June 27 2025. Now they want to list their company on the NSE SME platform. ABH Healthcare Limited is trying to get money from investors by doing this. The healthcare business of ABH Healthcare Limited is what they are focusing on.
About ABH Healthcare Limited
ABH Healthcare Limited is based in Ferozepur, Punjab. This company started out as ABH Healthcare Private Limited, in March 2021. Then ABH Healthcare Limited acquired Anil Baghi Hospital. They did this through a Business Transfer Agreement. After that ABH Healthcare Limited became a limited company in 2024. ABH Healthcare Limited is still based in Ferozepur, Punjab.
The company operates in the healthcare sector and is associated with Anil Baghi Hospital. Its proposed IPO is structured as a book-built SME issue and is expected to be listed on NSE Emerge.
ABH Healthcare SME IPO Details
| IPO Particular | Details |
|---|---|
| Company | ABH Healthcare Limited |
| IPO Type | SME IPO |
| Issue Type | Book Building |
| Exchange | NSE SME / NSE Emerge |
| Face Value | ₹10 per share |
| Issue Size | Up to 34.29 lakh shares |
| DRHP Filing Date | June 27, 2025 |
| IPO Price Band | To be announced |
| IPO Open Date | Date |
| IPO Close Date | Date |
| Listing Date | Date |
| Market Maker | Person |
Financial Performance
Financial information reported from the IPO documents indicates a stable foundation for the business. The reported annualized figures are as follows:
- Annualized Revenue: Approximately ₹48.51 crore.
- Annualized Profit After Tax (PAT): Approximately ₹4.43 crore.
Note: The company's performance and debt position must be carefully looked at before deciding to invest. Healthcare companies usually need a lot of money to spend on equipment, daily operations and other resources.
Grey Market Premium (GMP) Insights
The ABH Healthcare IPO GMP (Grey Market Premium) can change a lot based on how people feel about the market and how many people want to invest. Even though ABH Healthcare is part of the SME IPOs the GMP should not be seen as a real sign of the price when it starts trading.
Investors are advised to check the latest GMP closer to the opening date, as these unofficial premiums can fluctuate significantly.
Objectives of the IPO
The proposed IPO proceeds are intended to support critical corporate goals:
- Debt Management: Repayment or prepayment of certain borrowings.
- Operational Support: Meeting working-capital requirements.
- Inorganic Growth: Funding unidentified acquisitions.
- General Corporate Purposes: General operational and strategic needs.
Using proceeds for debt reduction may improve the company's financial health, while working-capital funding supports future expansion.
Expert Review & Key Considerations
ABH Healthcare operates in a sector with substantial long-term demand. The proposed NSE SME listing provides visibility and access to capital markets. However, investors should balance potential with the inherent risks of SME listings:
- Liquidity: SME stocks typically have lower liquidity than mainboard companies.
- Volatility: Share prices may experience significant movement post-listing.
- Valuation: Final evaluation should depend on the issue price and borrowing levels once finalized.
Investor Checklist
Before applying, ensure a review of the following:
- Final IPO price band and valuation metrics.
- IPO opening and closing dates.
- Minimum lot size and total investment requirement.
- Debt-to-equity ratios and total borrowing levels.
- Promoter shareholding and long-term growth strategy.
Conclusion
ABH Healthcare represents a significant upcoming entry in the healthcare SME segment. With a proposed issue of up to 34.29 lakh shares, the market awaits final pricing and subscription dates. While market sentiment (GMP) is a useful pulse, investors should base their final decisions on the official Red Herring Prospectus (RHP) and fundamental analysis.